학술논문

Long-term follow-up after a switch to bictegravir, emtricitabine, tenofovir alafenamide (B/F/TAF) from a boosted protease inhibitor-based regimen
Document Type
Journal
Source
HIV MEDICINE; AUG 2021, 22 p5-p5, 1p. Supplement: 2
Subject
Language
English
ISSN
14681293